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Recent reports of "lineage switching" from a lymphoid to macrophage phenotype have
left unresolved the question of whether such cells are functional macrophages or
nonfunctional products of differentiation gone awry. This study demonstrates that
several "macrophage-like" cell lines derived from v-Ha-ras-transformed pre-B cells have
gained the capacity to effectively present antigen in MHC-restricted fashion. Using an
assay involving the cocultivation of putative antigen-presenting cells with chicken
ovalbumin (cOVA) and a cOVA-specific T-cell hybridoma, "lineage switch" cell lines
were found to present antigen as effectively as macrophage-containing peritoneal
exudates. Neither the original pre-B-cell precursors nor B-cell lymphomas derived from
them present antigen. Thus, we have demonstrated that these "lineage switch"
macrophages are capable of antigen presentation, a mature differentiated function.
While gaining macrophage characteristics, these cells have also rearranged their
kappa light-chain immunoglobulin locus, suggesting that macrophage differentiation
and immunoglobulin rearrangement are not mutually exclusive processes. The existence
of both lymphoid and myeloid characteristics in a cell fully capable of antigen
presentation suggests greater plasticity in hematopoietic lineage commitment than
conventionally thought to be the case.
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INTRODUCTION
The concept that hematopoietic differentiation
involves an early and irreversible lineage com-
mitment is brought into question by numerous
observations of leukemias and lymphomas that
express myeloid or lymphoid markers outside
their respective lineages. The coexpression of dif-
ferentiation markers has been interpreted as
being either an aberrant phenomenon caused by
leukemogenesis (McCulloch, 1983) or a reflection
of the normal but transient existence of bipoten-
tial progenitors in hematopoiesis (Greaves et al.,
1986). In particular, the existence of a number of
transformed cell lines with both lymphoid and
macrophage characteristics has suggested a close
relationship between these lineages. Murine mac-
rophage cell lines have been derived from
lymphoid tumors and from in vitro trans-
formants induced either by murine leukemia
viruses or chemical carcinogens (Boyd and
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Schrader, 1982; Holmes et al., 1986; Hanecak et
al., 1989). Three groups have studied systems in
which a transition from a lymphoid to a mac-
rophage phenotype could be induced. Klinken et
al. (1988) demonstrated that B lymphoid cells
from transgenic mice that express c-myc using the
immunoglobulin mu enhancer could be induced
to take on macrophage-like characteristics when
infected with a retrovirus expressing v-raf.
Davidson et al. (1988) showed that a v-Ha-ras-
transformed lymphoid cell line could be stimu-
lated by lipopolysaccharides (LPS) to differen-
tiate along either the lymphoid pathway into
pre-B-like cells or along the myeloid pathway
into macrophage-like cells. Recently, Borzillo et
al. (1990) reported the CSF-l-dependent mac-
rophage lineage transition of a pre-B-cell line
expressing the human CSF-1 receptor.
The macrophage-like cell lines that have been
derived from B lymphoid cells have been classi-
fied as macrophage on the basis of their mor-
phology, expression of MAC-l, MAC-2, c-naph-
thyl acetate esterase and lysozyme, and their
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ability to phagocytose latex beads. More func-
tional assays for antigen presentation and tumor-
icidal activity that would establish whether these-
cells could act in vivo similarly to authentic mac-
rophages have not been presented. In this paper,
we demonstrate the ability of several macro-
phage cell lines derived from v-Ha-ras-transfor-
med pre-B cells to present antigen to a T-helper
cell hybridoma.
of BglII-digested DNA, using a probe for the eco-
tropic MuLV env gene, revealed similar MoMuLV
integration fragments in R2 and tumor 4 (Fig.
1B). The MoMuLV genome possesses a BglII site
within env, such that the foregoing hybridization
would detect a fragment extending from that
BglII site to a BglII site in the host-cell genome
flanking the 3’ terminus of the provirus. These
data demonstrate that the putative macrophage
tumor was derived from the pre-B-cell line.
RESULTS
A tumor consisting of adherent cells with a mac-
rophage morphology was identified during our
studies on the tumor progression of a pre-B
lymphoid cell line expressing v-H-ras (Chen et
al., 1991). This tumor, designated tumor 4, was
derived from a clonal cell line, designated R2,
that was generated by infection of fresh murine
bone marrow with a mixture of a v-Ha-ras-
expressing retrovirus and Moloney murine leu-
kemia virus (MoMuLV) (Schwartz et al., 1986b).
The R2 cell line was classified as being a pre-B
cell on the basis of several criteria. It possessed a
blast-cell morphology with a large nucleus and
scant cytoplasm. It expressed the B lineage-
specific marker, B220 (Coffman and Weissman,
1981). Though not expressing a detectable immu-
noglobulin mu chain, R2 showed a rearrange-
ment in the DNA of’that locus. The immunoglob-
ulin kappa-chain locus was in a germline
configuration.
Tumor 4 Cells Possess Macrophage
Characteristics
Tumor 4 was initially suspected to be a macro-
phage because of the large size of its cells and its
adherent growth in cell culture. Microscopic
examination of Wright-Giemsa-stained cells con-
firmed their large size and revealed the cells of
tumor 4 (Fig. 2B) to have a much more extensive
and granular cytoplasm than R2 (Fig. 2A). An
immunoperoxidase detection procedure found
tumor-4 cells to have retained some expression of
B220, and to have gained expression of high
levels of MAC-1 (data not shown). MAC-1 is gen-
erally considered to be a marker for cells of the
myeloid lineage (Springer et al., 1979). Histo-
Tumor 4 is Derived from the R2 Cell Line
In order to ascertain whether we had identified a
probable instance of lineage switching, it was
necessary to demonstrate that tumor 4 was
derived from R2. To that end, the sites of inte-
gration of the v-Ha-ras-expressing retrovirus and
MoMuLV were compared between the tumor and
the cell line. Southern hybridization analysis of
EcoRI-digested DNA with a v-Ha-ras probe
showed that tumor 4 contained the same 5.3-kb
proviral integration fragment as R2 (Fig. 1A).
This proviral integration fragment is defined by a
3’ EcoRI site internal to the viral genome and a 5’
EcoRI site peculiar to the site of integration. In
addition to the 5.3-kb fragment, there is a 23-kb
fragment representing the endogenous c-Ha-ras
in all the DNAs. Southern hybridization analysis
FIGURE 1. Viral intergrations. Southern blot analysis of
DNAs from liver (L), R2, and tumor 4 (T4). (A) DNA was
digested with EcoRI and 10/g of each sample was
electrophoresed through 0.8% agarose. The blot was probed
for v-Ha-ras. (B) DNA was digested with BglII. The blot was
probed for murine ectotropic env sequences. Size markers are
the positions of an ethidium bromide-stained HindIII digest of
bacteriophage & and are denoted in kilobases.ANTIGEN PRESENTATION AFTER LINEAGE SWITCH 251
chemical procedures revealed a high level of c-
naphthyl acetate esterase activity in tumor-4
cells, which is not found in R2 cells (data not
shown). This is an enzyme activity generally
associated with cells of the monocyte-macro-
phage lineage (Rogers et al., 1980). Tumor-4 cells
(Fig. 2B) were positive for the nonspecific phago-
cytosis of latex beads, whereas R2 cells (Fig. 2A)
were not. Nonspecific phagocytosis is another
marker of the monocyte-macrophage lineage
(Raschke et al., 1978). These data strongly sug-
gest a macrophage phenotype for tumor-4 cells.
At late stages of myeloid differentiation, the
levels of c-myc and c-myb mRNA decrease,
whereas the level of c-fms mRNA increases
(Gonda and Metcalf, 1984; Sheng-Ong et al.,
1987). The levels of mRNA from these proto-
oncogenes detected in tumor-4 cells were consist-
ent with tumor 4 having advanced to a late stage
of myeloid differentiation. Cytoplasmic poly A
/
RNAs of the parental R2 cell line, tumor 4, and
six other tumors derived from R2 that had
lymphoid characteristics were examined by
FIGURE 2. Nonspecific phagocytosis of latex beads. The cells
were Wright-Giemsa stained and photographed at 200x
magnification. (A) R2, and (B) tumor 4.
FIGURE 3. RNA analyses of c-myc, c-myb, and c-fins.
Northern blot analyses were performed on polyA RNA from
R2 and seven tumors (T1-T7). Each sample of RNA was the
polyA fraction selected from 150/g of total cytoplasmic RNA.
One blot (upper panel) was probed successively for both c-myc
and ]/2-microglobulin, and the other blot (lower panel) was
probed successively for c-myb, c-fins, and rGAPDH.252 J.D. BRETZ et al.
Northern hybridization analysis (Fig. 3). One blot
was hybridized successively with c-myc and ]/2-
microglobulin probes. Another blot was
hybridized successively with c-myb, c-fms, and
rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probes. Hybridization to the ]/2-micro-
globulin and GAPDH probes provided a control
for gel loading. Tumor-4 cells clearly show
reduced levels of c-myc and c-myb expression in
comparison to R2 cells and lymphoid tumors. In
contrast, c-fms expression is elevated in tumor-4
cells. A cell line with macrophage characteristics
has also been isolated from tumor-5 cells, which
show elevated c-fins expression (Fig. 3).
Another aspect of macrophage function is the
ability to release cytokines in response to LPS
stimulation. We examined the presence of IL-1,
IL-6, and TNF in the media of cells cultured in
the presence or absence of 10 tg/ml of LPS for
24 hr. Cellular proliferation assays for IL-1 and
IL-6, and a cytotoxicity assay for TNF revealed
varying levels of cytokine release for six sub-
clones of tumor 4, whereas the parental R2 pre-B-
cell line did not elaborate any of these cytokines
except low levels of IL-1 (Table 1). The LPS-
inducible release of cytokines was again consist-
ent with a macrophage phenotype for tumor-4
cells.
Tumor 4 Cells AlsoShow Differentiated
Lymphoid Characteristics
Davidson et al. (1988) found that a v-Ha-ras-
transformed lymphoid cell line could be stimu-
lated to differentiate along either the myeloid or
lymphoid pathways. Because tumor-4 cells
showed a variety of DNA rearrangements in the
kappa light-chain locus (data not shown), it was
of interest to determine whether the cells that
had gone on to rearrange the kappa locus were
the same cells that had progressed toward a mac-
rophage phenotype or whether the tumor-4 cells
were a mixed population of B cells and macro-
phages. To that end, tumor-4 cells were plated in
soft agar medium and six subclones were recov-
ered. Southern hybridization analysis of EcoRI-
digested DNA isolated from the subclones
showed that they all contained the same 5.3-kb v-
Ha-ras proviral integration fragments as R2 and
tumor-4 cells (data not shown; see Fig. 1A). The
six subclones of tumor-4 possessed the same
myeloid characteristics described before for the
uncloned tumor, but varied in their pattern of
kappa light-chain gene rearrangement. Southern
hybridization analysis of BamHI-digested DNAs
with a kappa probe revealed that subclones 3 and
5 possessed one germline and one rearranged
kappa allele, and subclones 1, 2, 4, and 6 pos-
sessed rearrangements in both alleles (Fig. 4). All
the subclones possessed a rearranged BamHI
fragment of approximately 7 kb. Tumor 4 was
apparently derived from an outgrowth of R2 that
had undergone this rearrangement. Some sub-
clones then proceeded to rearrange their other
kappa allele. Clearly, tumor 4 contained cells that
individually had differentiated along both the
lymphoid and myeloid pathways.
Having observed kappa light-chain rearrange-
ments in macrophage subclones of tumor 4, we
next examined the status of immunoglobulin
expression by Northern blot analysis. Kappa
light-chain transcript could not be detected (data
TABLE
LPS-Induced Cytokine Release by Tumor-4 Macrophage Subclones
IL-1 (U/ml) IL-6 (U/ml) TNF (U/ml)
-LPS +LPS -LPS +LPS -LPS +LPS
R2 0 2 0 0 0 0
T4.1 0 2 0 0 0
T4.2 0 6 0 100 0 40
T4.3 0 6 0 1500 0 85
T4.4 0 19 0 39 0 34
T4.5 4 0 0 0 0
T4.6 0 4 0 35 0 0
aThe capacity of cell lines to release the cytokines IL-1, IL-6, and tumor necrosis factor (TNF) determined by assaying culture supernatants. For this purpose, cell lines
incubated for 24 h at 2.5x105 cells/ml, with 10-pg/ml LPS in RPMI 1640 supplemented with 10% fetal calf and 5x10 M 2-mercaptoethanol. Culture supernatants
collected, passed through 0.2-micron filter, and stored at -70C until assayed. IL-1 activity assayed by its ability to induce proliferation of D10.G4.1 cells in the
presence of Concanavalin A described by Ayala et al. (1990b). IL-6 activity determined by its ability to induce the proliferation of the 7TD1 B-cell hybridoma
previously described by Hultner et al. (1989). TNF activity assessed by its cytotoxicity to WEHI-164 clone 13 cells previously described by Ayala et al. (1990a). The
relative units of cytokine activity determined by comparison of the activity of dilution series of experimental supernatants to the activities of dilution series of purified
human IL-1 (Genzyme), recombinant human IL-6 (Amgen Corp.) murine TNF-alpha (Amgen Corp.) standards.ANTIGEN PRESENTATION AFTER LINEAGE SWITCH 253
not shown). A mu heavy-chain probe revealed a
diverse range of RNAs in the macrophage sub-
clones (Fig. 5) that correspond in size to 1.9-, 2.1-,
2.3-, and 2.9-kb transcripts reported to be
initiated in the mu-swit.ch region of myeloid cell
lines (Kemp et al., 1980). The R2 pre-B-cell line
possesses predominantly larger RNA species that
include those that. correspond in size to mature
mu mRNAs of 2.4 and 2.7 kb. These species are
diminished upon lineage switch. Comparison to
a hybridization of the same blot with a probe for
GAPDH (Fig. 5) shows the R2 RNA to be
underloaded and thus the diminution of mu tran-
scription in the macrophage is even more dra-
matic than apparent from casual inspection of the
data. Apparently, the macrophage subclones of
tumor 4 lose the capacity to transcribe functional
mu mRNA, even though the rearrangement of
the kappa locus suggests progress in lymphoid
differentition.
Since CD45 isoforms have been reported to be
lineage-specific (Ralph et al., 1987; Saga et al.,
1987; Streuli et al., 1987), the expression of this
surface marker was examined among the sub-
clones of tumor 4. An immunoper0xidase-detec-
tion procedure detected B220, the B lymphoid
isoform of CD45, in tumor-4 cells. The expression
of CD45 was further examined among the tumor-
4 subclones in order to determine the relative
expression of the B220 isoform in comparison to
the isoform that predominates in myeloid cells.
Recently, Chang et al. (1989) described the use of
a reverse transcription-polymerase chain reaction
(RT-PCR) technique to determine the pattern of
alternate exon use in CD45 expression of hemato-
poietic cells. They found that B lymphoid cell
lines uniquely expressed a form of CD45 mRNA
possessing three optional exons, whereas two
myeloid cell lines (a macrophage and a mast cell)
predominantly expressed a form lacking these
exons. We utilized RT-PCR to examine CD45
expression among R2 and the subclones of tumor
4 (Fig. 6). All of the cell lines expressed multiple
species of CD45 mRNA. Subclones 2, 3, 4, and 6
expressed a CD45 mRNA containing three
optional exons, typical of B lymphoid cells,
whereas subclones 1 and 5 predominantly
expressed mRNA lacking these exons, typical of
myeloid cells. R2 expressed the expected three
exon B lymphoid isoform. Thus, the pattern of
CD45 expression is heterogeneous among mac-
rophage subclones of the same tumor.
FIGURE 4. Kappa light-chain
rearrangements. Southern blot
analysis of DNAs from liver (L), R2,
and six subclones of tumor 4 (1-6).
DNA was digested with BamHI and
10/2g of each sample was
electrophoresed through a 0.8%
agarose. The blot was probed for
kappa light-chain constant region
sequences. Size markers are the
positions of an ethidium bromide-
stained HindIII digest of
bacteriophage 2 and are denoted in
kilobases.254 J.D. BRETZ et al.
FIGURE 5. Expression of mu
heavy-chain RNA. Northern blot
analysis was performed by poly A
RNA from R2 and six subclones of
tumor 4 (1-6). Each sample of RNA
was the poly A fraction selected
from 100/g of total cytoplasmic
RNA. The blot was probed for mu
heavy chain. The positions of
ethidium bromide-stained rRNAs
are noted on the right. The positions
of mu RNA species are marked on
the left and denoted in kilobases.
The lower panel shows the same
blot probed for GAPDH as a control
for loading.
The Subclones of Tumor 4 Can Function
Effectively in Antigen Presentation
In order to test the ability of tumor-4 subclones to
present antigen, an assay system required an
antigen-specific T-helper cell line that could be
stimulated to produce interleukin-2 (IL-2) upon
presentation. For these experiments, the putative
antigen-presenting cells were cocultivated with a
T-cell hybridoma specific for chicken ovalbumin
(cOVA) and restricted for I-A
d (the haplotype for
BALB/c), DO.11.10/54.4. In the presence of
cOVA, authentic macrophages such as those in a
peritoneal exudate stimulate the hybridoma to
produce IL-2 (Fig. 7A). IL-2 production was
assayed by the application of media supernatants
from cocultivations to an IL-2-dependent cell
line, CTLL-2. All of the macrophagelike tumor-4
subclones displayed antigen-presentation
capacities comparable to peritoneal exudates
(Fig. 7A). Furthermore, all of the tumor-4 sub-
clones showed antigen-presentation capacities
dramatically greater than either the parental R2
pre-B-cell line or tumor 1, a B-cell tumor derived
from R2 (Fig. 7A). IL-2 production was depen-
dent on the presence of cOVA during coculti-
vation of presenting cells with cells of the helper
T-cell hybridoma. Supernatants produced in theANTIGEN PRESENTATION AFFER LINEAGE SWITCH 255
T4 subclones
C 6 5 4 3 2 1 M M M R2M
No. of Base
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!23
FIGURE 6. RT-PCR analysis of CD45. RT-PCR was performed on the polyA RNAs of R2, the six subclones of tumor 4, and
P388D1 (a myeloid control). The products were electrophoresed through 2% agarose and stained with ethidium bromide. (C) 3-
exon plasmid control; (1-6) T4 subclones; (M) 123-bp ladder; (Me). P388D. PCR products smaller than the 0 exon product may
represent an RNA species lacking an additional exon (Chang and Esselman, unpublished results).
absence of cOVA were analyzed for all the cell
lines and the values for IL-2 production were
found to be near zero (data not shown). These
control values were subtracted from those deter-
mined for supernatants produced in the presence
of cOVA to generate the data presented in Figs.
7A, 7B, and 7C. IL-2 production was also depen-
dent on the presence of T-cell hybridoma cells.
Supernatants produced by incubations of puta-
tive presenting cells with cOVA in the absence of
T-cell hybridoma cells had no detectable IL-2
(data not shown). The ability to present antigen
was not stimulated by exposure to LPS for any of
these cell lines (data not shown). A macrophage-
like outgrowth from tumor 5 (also derived from
R2) and the cells of a macrophagelike tumor
derived from the pre-B-cell line R1 (9) showed
levels of antigen presentation similar to those
observed for the tumor-4 subclones (Fig. 7B). The
ability to present antigen, therefore, may be a
common phenomenon among v-Ha-ras-transfor-
med B lymphoid cells that acquire macrophage-
like characteristics.
Authentic antigenic presentation should be
MHC-restricted, so all of the putative antigen-
presenting cells were also c6cultivated with a T-
cell hybridoma specific for cOVA and restricted
for I-Aq, 3Q023-24.4. As exemplified by subclone
4 of tumor 4 (T4.4) and the macrophage tumor
derived from R1 (RIT), the antigen presentation
observed is MHC-restricted (Fig. 7C).
I-A Expression
Antigen presentation to T cells requires Ia
expression and the observation of I-Aa-restricted
presentation (Fig. 7C) indicates that these "lin-
eage switch" macrophages express I-Ad. In order
to assess whether the acquisition of presentation
capacity correlated with acquisition of Ia
expression, in particular I-Aa, we performed flow
cytometry with FITC-conjugated antimouse I-Aa
on the macrophage cell lines and their pre-B-cell
precursors. Although both R1 and R2 (pre-B
cells) displayed no detectable I-Aa, the macro-
phage cell lines represented by RIT and T4.4
showed a low expression of I-A
d (Fig. 8).
DISCUSSION
This study demonstrates the capacity of several
macrophage-like tumor cell lines derived from v-
Ha-ras-transformed pre-B-cell lines to present
antigen with MHC-retriction. This finding estab-
lishes that cells having undergone "lineage
switching" can perform a function normally
associated with a fully differentiated macrophage256 J.D. BRETZ et al.
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FIGURE 7
or B cell. Although numerous examples exist of B
lymphomas with the capacity to present antigen
(Chesnut et al., 1982; Walker et al., 1982), neither
the pre-B-cell precursors of the macrophage-like
cell lines nor B-cell lymphoma cell lines derived
from those precursors could present antigen.
Thus, the capacity to present antigen appears to
correlate with the differentiation of these cells
along the macrophage lineage. Indeed, two cell
FIGURE 7. Antigen presentation. (A) Antigen-presentation
.assays were performed on R2, the tumor-4 subclones (4.1-4.6),
tumor (a B-cell tumor derived from R2), and peritoneal
exudates (pM). (B) Antigen-presentation assays were
performed on R2, a macrophage outgrowth of tumor 5 (T5;
derived from R2 in a different animal), R1 (another pre-B-cell
line transformed by v-Ha-ras), and RIT (a macrophage tumor
derived from R1). (C) Antigen-presentation assays were
performed on a tumor-4 subclone (T4.4) and RIT with DO-
11.10/54.4 (I-Aa-restricted) or 3Q023-24.4 (I-Aq-restricted).
Each point represents an average value obtained from a
dilution series for each presentation supernatant, testing the
response of CTLL-2 cells to IL-2 in those supernatants. The
results shown are representative of at least two experiments
with each cell line.
lines with the most dramatic level of antigen
presentation had lost expression of the B-cell iso-
form of CD45 and displayed a pattern of CD45
more typical of a myeloid cell (subclones 1 and 5,
Fig. 6; T4.1 and T4.5, Fig. 7A). Perhaps, loss of the
B-cell isoform of CD45 is indicative of further
maturation along the myeloid lineage. It may be
worthwhile to investigate the role of CD45 in
macrophage function. The fact that similar
antigen-presentation abilities were found in mac-
rophage derivatives of two completely indepen-
dent cell lines (R1 and R2) suggests the generality
of this phenomenon.
Because it is well established that IL-1 along
with antigen presentation is an important coacti-
vator of T cells, it is surprising that the induc-
ibility of cytokine release by LPS (Table 1) does
not correlate with the effectiveness of antigen
presentation by the T4 subclones (Fig. 7A).ANTIGEN PRESENTATION AFTER LINEAGE SWITCH 257
Apparently the low levels of IL-1 that some of
these macrophages are capable of elaborating is
sufficient for T-cell activation. The observation
that two of the best lines for antigen presentation
(T4.1 and T4.5) have a weak response to LPS sug-
gests that LPS-induced cytokine release may not
be an adequate measure in itself for evaluating
macrophage function.
The "lineage switch" macrophages reported
here express a low level of Ia (Fig. 8). This is con-
sistent with the previous report of Davidson et al.
(1988). The precursor pre-B cells lack detectable
Ia..Perhaps Ia expression is the critical property
determining the capacity to present antigen
among these cells. Certainly, Ia expression is
necessary for antigen presentation, but its suf-
ficiency for antigen presentation among the cell
lines we have studied will require further experi-
mentation.
The six macrophagelike subclones of tumor 4,
while possessing a common rearranged kappa
allele, displayed a variety of kappa light-chain
gene rearrangements at their other kappa allele.
Compared to their parental cell line, these cells
have progressed along the B as well as the
monocyte/macrophage lineage. The varying
rearrangements of one kappa allele suggest
rearrangement subsequent to macrophage con-
version and that at least certain elements of
lymphoid and macrophage differentiation pro-
grams are not mutually exclusive. The fact that
the R2 cell line can also generate a lymphoma
(T1, Fig. 7A) that expresses both mu and kappa
chains (data not shown) demonstrates the poten-
tial of this cell line to differentiate quite far along
either the lymphoid or macrophage pathways.
The relationship between lymphoid and mac-
rophage differentiation revealed in these cells
differs somewhat from that seen in cases of "lin-
eage switch" previously reported. Klinken et al.
(1988) found "lineage switch" macrophages at
both the pre-B- and B-cell stages of immunoglob-
ulin rearrangement. However, they did not find
macrophages that had progressed in their immu-
noglobulin rearrangement compared to their
lymphoid cell precursors, as we have. Davidson
et al. (1988), examining v-Ha-ras-transformants
similar to those reported here, could induce those
cells to differentiate into either lymphoid or mac-
rophage cells upon exposure to LPS. The lymph-
oid derivatives they reported did not progress
beyond the pre-B-cell stage, whereas we have
identified an immunoglobulin-producing tumor
derived from a pre,B-cell line that also gave rise
to a macrophage tumor. Perhaps the more com-
plex environment provided during tumor chal-
R2
R1
T4.4
RIT
FIGURE 8. I-A expression. Flow
cytometry was performed on R1, R2,
T4.4, and RIT after reactions with
FITC-conjugated anti-I-A (solid
line) or, as a control, FITC-
conjugated mouse IgG2B,K (dashed
line). For R1 and R2, the plots of
experimental and control are
FLUORESCENCE virtually coincidental.258 J.D. BRETZ et al.
lenge allowed the cells described here to more
fully develop along the lymphoid lineage when
that pathway was selected. At any rate, the v-Ha-
ras-transformed pre-B cells described here seem
truly bipotential.
The ability of these cells that undergo an
apparent "lineage switch" to perform a fully dif-
ferentiated function presents the possibility that
they may represent an unusual but normal subset
of hematopoetic cells rather than an oddity
induced by transformation. The existence of both
lymphoid and macrophage characteristics in a
cell fully capable of antigen presentation sug-
gests greater plasticity in hematopoietic lineage
commitment than conventionally thought to be
the case.
MATERIALS AND METHODS
Cell Lines
R1 and R2 are v-Ha-ras-transformed murine pre-
B-cell lines described in Schwartz et al. (1986b).
Tumors derived from R1 and R2 were generated
as described in Schwartz et al. (1986a, 1986b) in
syngeneic BALB/c mice and in BALB/c athymic
nude mice. Briefly, cells were washed twice in
RPMI 1640 and were then resuspended in the
same at 8x106 cells per ml. Five-week-old mice
were injected intraeritoneally with 0.25 ml of
the cellular suspension. Tumor 4, in particular,
was isolated from an inguinal lymph node at 74
days postinjection. Tumor cell lines were readily
produced from explanted tumors by dispersal
and transfer to feeder cultures of adherent bone
marrow cells (Whitlock et al., 1983). All of these
cell lines were cultured over feeder cells in RPMI
1640 supplemented with 5% fetal calf serum and
5x10
-5M 2-mercaptoethanol.
The subclones of tumor 4 were generated from
single colonies grown in soft agar medium as
described by Whitlock et al. (1983). The T-cell
hybridoma, DO-11.10/54.4, was a generous gift
of Drs. Philippa Marrack and John Kappler
(University of Colorado, Denver) (White et al.,
1983). This hybridoma is specific for’ chicken
ovalbumin in the context of I-A
d and cross reacts
weakly with chicken ovalbumin in the context of
I-Ab. 3Q023-24.4, another T-cell hybridoma, was
also a gift of Drs. Marrack and Kappler. This
hybridoma is specific for chicken ovalbumin in
the context of either I-Aq or I-E. CTLL-2 is a T-cell
line responsive to IL-2 and was obtained from the
ATCC. All of these cell line were cultured in
RPMI 1640 supplemented with 10% fetal calf
serum and 5x10-5M 2-mercaptoethanol in the
absence of any feeder cells.
Peritoneal exudates containing macrophages
were produced from BALB/c mice treated 1
week previously with a 0.5-ml intraperitoneal
injection of pristane.
Nucleic Acid Analysis
Cytoplasmic RNA was isolated from actively
growing cells by a sodium dodecyl sulfate-urea
procedure as described by Schwartz et al. (1981).
Poly A
/ RNA was selected by oligo-dT cellulose
chromatography (Aviv and Leder, 1975). RNA
was denatured, electrophoresed in a formal-
dehyde-1% agarose gel (Rave et al., 1979), and
transferred to Nytran (Schleicher and Schuell)
(Thomas, 1980).
High molecular weight DNA was isolated from
nuclei collected in the preceding RNA isolation
procedure as described in Schwartz et al. (1986b).
DNA was digested with restriction enzymes as
noted in the figure legends, electrophoresed
through 0.8% agarose, and transferred to Nytran
(Southern, 1975).
Hybridization probes were prepared by nick
translation (Rigby et al., 1979) through the incor-
poration of [Or-32p] dATP (3000Ci/mmol; ICN).
The v-Ha-ras probe was the replicative form of
phage M13mp10 containing a 0.46-kb EcoRI frag-
ment corresponding to v-Ha-ras encoding
sequences (Ellis et al., 1980). The env probe was a
0.8-kb BamHI fragment from the env region of
Friend murine leukemia virus and is specific for
the env sequences of murine ecotropic retro-
viruses (Silver and Kozak, 1986). The c-myc probe
was the 4.7-kb genomic HindIII fragment of
murine c-myc (Stanton et al., 1984). The murine c-
myb probe was a cloned 2.4-kb cDNA (a generous
gift of Dr. Timothy Bender, University of Vir-
ginia, Charlottesville). The fms probe was a
cloned 2.7-kb ClaI-BamHI fragment of the
McDonough strain of feline sarcoma virus
(Donner et al., 1982). The murine ]/2-microglobu-
lin probe was a cloned 0.5-kb cDNA (Parnes et
al., 1981). The rat glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) probe was a cloned
1.3-kb cDNA (Fort et al., 1985). The murineANTIGEN PRESENTATION AFTER LINEAGE SWITCH 259
kappa light-chain probe was the replicative form
of phage M13mp10 containing a genomic 0.48 kb
HpaI-BglII fragment extending from a point
about 50 base pairs within the 5’ terminus of the
kappa light-chain constant region gene to the
poly A addition site (Seidman and Leder, 1978).
The murine mu heavy-chain probe was a cloned
cDNA (/12) that extends from CH2 to the 3’-
untranslated region of the secreted form of mu
mRNA (Rogers et al., 1980). All hybridizations
were performed under aqueous conditions in 5x
SSC at 65C and washed to a stringency of 0.1x
SSC at 65 C.
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
RT-PCR was performed according to the pro-
cedure of Chang et al. (1989, 1991) using
poly A
/ RNA as substrate. The primers were
a sense primer specific to exon 2
(GCCCTTCTGGACACAGAAGT, base positions
167-186) and an antisense primer specific to exon
9 (AATTCACAGTAATGTTCCCAAACAT; base
positions 764-740) of the cDNA of murine CD45
(Thomas et al., 1987). cDNA was prepared by
incubating 1/g of poly A
/ RNA for 60 min at
37C with 200 units of MoMuLV reverse tran-
scriptase in a 20-tl reaction volume containing
50mM Tris-HC1 (pH 8.3), 75mM KC1, 3mM
MgCI2, 5 mM DTT, 100’/g/ml BSA, 40 units RNa-
sin, 500/M dNTP, and 200ng of antisense
primer. A 5-/tl aliquot was used directly for PCR
amplification in a 50-/A reaction volume contain-
ing 50mM KC1, 10 mM Tris-HC1 (pH 9.3), 3mM
MgCI2, 0.1% w/v gelatin, 500/M dNTP, 400 ng
of sense and antisense primers, and 2.5 units of
Taq polymerase.’PCR was performed in a DNA
Thermal Cycler (Perkin-Elmer-Cetus, Inc.) for 24
cycles. Each cycle consisted of 40 s at 94C for
denaturation, 15 s at 55C for annealing, and 30 s
at 72C for elongation. The first cycle was pre-
ceded by a 5-min incubation at 94C and the last
cycle followed by a 4-min incubation at 72 C.
Cytological Analyses
Cells were cytocentrifuged onto a microscope
slide and allowed to air dry overnight. The cells
were then incubated with either rat anti-B220
(monoclonal 14.8) or rat anti-MAC-1 (Boehringer
Mannheim). Goat antirat immunoglobulin-
horseradish peroxidase (Boehringer Mannheim)
was used in a secondary incubation for detection.
The presence of c-naphthyl acetate esterase was
determined by cytochemical staining (Yam et al.,
1971) with a Sigma research kit. Nonspecific
phagocytosis of latex beads was assayed by the
method of Raschke et al. (1978).
Antigen Presentation
Assays for antigen presentation were performed
in a manner similar to that described by Marrack
et al. (1989). Briefly, the cell lines to be assayed
for antigen presentation were titrated into 200-tl
microcultures containing 105 cells of either the T-
cell hybridomas DO-11.10/54.4 or 3Q023-24.4,
both of which produce IL-2 in response to the
presentation of chicken ovalbumin (cOVA) in the
context of I-A
d or I-Aq, respectively. These assays
were carried out in RPMI 1640 supplemented
with 10% fetal calf serum, 5x10
-5M 2-mercapto-
ethanol and, where required, cOVA at 1 mg/ml.
After 24 hr, incubation supernatants from these
cultures were assayed for IL-2 using CTLL-2, an
IL-2-dependent cytotoxic T-cell line. Twofold ser-
ial dilutions of supernatants were added to 5x103
CTLL-2 cells in 100-/.tl microcultures and incu-
bated for 48 hr at 37 C. MTT (Sigma), a substrate
for production of a colored product indicative of
cell survival (Mosmann, 1983), was added at
0.5mg/ml and the cultures incubated for an
additional 4 hr at 37 C. Acid-isopropanol (40-
mM HC1) was then added to dissolve the MTT
formazan reaction product. The optical density of
each well was quantitated by an ELISA reader at
a wavelength of 540 nm. The specific activity of
IL-2 in the supernatants was determined by com-
parison to a standard curve produced through
the use of purified recombinant IL-2 (Cetus Inc.).
Flow Cytometry
Cells were stained in PBS, 2% FCS with either
FITC-conjugated monoclonal antibody AMS-32.1
(antimouse I-Ad) (Phar Mingen) or FITC-conju-
gated mouse IgG2b, K (Phar Mingen) as an isot-
ype-matched control. Cells were then fixed in
PBS, 2% FCS, 0.5% formaldehyde, and stored at
4C until analysis. Flow cytometry was perfor-
med using an Ortho Diagnostics Cytofluoro-
graph 50-H.260 J.D. BRETZ et al.
ACKNOWLEDGMENTS
This work was supported by Public Health Service
grants CA45360 (RCS) and GM35774 (WJE) and by a
grant from the Elsa U. Pardee Foundation (RCS). We
are indebted to Alfred Ayala for the cytokine assays.
The authors thank Donna Paulnock for helpful dis-
cussions, and Susan Conrad and Michele Fluck for
thoughtful comments on this manuscript.
(Received October 8, 1991)
(Accepted November 22, 1991)
REFERENCES
Aviv H., and Leder P. (1975). Purification of biologically
active globulin messenger RNA by chromatography on oli-
gothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69:
1408-1412.
Ayala A., Perrin M.M., Meldrum D.R., Eretel W., and Chau-
dry I.H. (1990a). Hemorrhage induces an increase in serum
TNF which is not associated with elevated levels of endo-
toxin. Cytokin 3: 170-175.
Ayala A., Perrin M.M., Wagner M.A., and Chaudry I.H.
(1990b). Enhanced susceptibility to sepsis following simple
hemorrhage: Depression of Fc and C3b receptor-mediated
phagocytosis. Arch. Surg. 125: 70-75.
Borzillo G.V., Ashmun R.A., and Sherr C.J. (1990). Macro-
phage lineage switching of murine early pre-B lymphoid
cells expressing transduced fins genes. Mol. Cell. Biol. 10:
2703-2714.
Boyd A.W., and Schrader J.W. (1982). Derivation of macro-
phage-like lines from the pre-B lymphoma ABLS 8.1 using
5-azacytidine. Nature 2’97: 691-693.
Chang H.-L., Lefrancois L., Zaroukian M.H., and Esselman
W.J. (1991). Developmental expression of CD45 alternate
exons in murine T cells. Evidence of additional exon use. J.
Immunol. 147:1687-1693.
Chang H.-L., Zaroukian M.H., and Esselman W.J. (1989). T200
alternate exon use in murine lymphoid cells determined by
reverse transcription-polymerase chain reaction. J. Immu-
nol. 143: 315-321.
Chen S.-C., Redenius D., and Schwartz R.C. (1991). Tumor-
igenesis of a v-Ha-ras-expressing pre-B cell line selects for
c-myc activation. Biochem. Biophys. Res. Comm. 178:
1343-1350.
Chesnut R.W., Colon S.M., and Grey H.M. (1982). Antigen
presentation by normal B cells, B cell tumors and macro-
phages: Functional and biochemical comparison. J. Immu-
nol. 128:1764-1768.
Coffman R.L., and Weissman I.L. (1981). A monoclonal anti-
body that recognizes B cells and B cell precursors in mice. J.
Exp. Med. 153: 269-279.
Davidson W.F., Pierce J.H., Rudikoff S., and Morse H.C.
(1988). Relationships between B cell and myeloid differen-
tiation. J. Exp. Med. 168: 389-407.
Donner L., Fedele L.A., Garon C.F., Anderson S.J., and Sherr
C.J. (1982). McDonough felin.e sarcoma virus: Characteriz-
ation of the molecularly cloned provirus and its feline onco-
gene (v-fins). J. Virol. 41: 489-500.
Ellis R.W., De Feo D., Maryak J.M., Young H.A., Shih T.Y.,
Chang E.H., Lowy D.R., and Scolnick E.M. *(1980). Dual
evolutionary origin for the rat genomic genetic sequences
of Harvey murine sarcoma virus. J. Virol. 36: 408-420.
Fort P., Marty L., Piechaczyk M., E1 Salrouty S., Dani C.,
Jeanteur J., and Blanchard J.M. (1985). Various rat adult tis-
sues express only one major mRNA species from the glyc-
eraldehyde-3-phosphate dehydrogenase multigenic family.
Nucl. Acids Res. 13: 1431-1442.
Gonda T.J., and Metcalf D. (1984). Expression of myb, myc and
fos proto-oncogenes during the differentiation of murine
myeloid cells. Nature 310: 249-251.
Greaves M.F., Chan L.C., Furley A.J.W., Watt S.M., and Mol-
gard H.W. (1986). Lineage promiscuity in hemapoietic dif-
ferentiation and leukemia. Blood 67:1-11.
Hanecak R., Zovich D.C., Pattengale P.K., and Fan H. (1989).
Differentiation ’in vitro of a leukemia virus-induced B-cell
lymphoma into macrophages. Mol. Cell. Biol. 9: 2264-2268.
Holmes K.L., Pierce J.H., Davidson W.F., and Morse H.C.
(1986). Murine hematopoetic cells with pre-B or pre-
B/myeloid characteristics are generated by in vitro trans-
formation with retroviruses containing fes, ras, abl, and src
oncogenes. J. Exp. Med. 164: 443-457.
Hultner L., Szots H., Welle M., Van Snick J., Moeller J., and
Dormer P. (1989). Mouse bone marrow-derived interleukin
3-dependent mast cells and autonomous sublines produce
interleukin 6. Immunology 67: 408-413.
Kemp D.J., Harris A.W., and Adams J.M. (1980). Transcripts
of the immunoglobulin C/ gene vary in structure and splic-
ing during lymphoid development. Proc. Natl. Acad. Sci.
USA 77: 7400-7404.
Klinken S.P., Alexander W.S., and Adams J.M. (1988). Hema-
poietic lineage switch: v-raf ongene converts E/-myc
transgenic B cells into macrophages. Cell 53: 857-867.
Marrack P.; McCormack J., and Kappler J. (1989). Presentation
of antigen, foreign major histocompatibility complex pro-
teins and self by thymus cortical epithelium. Nature 338:
503-505.
McCulloch E.A. (1983). Stem cells in normal and leukemic
hemopoiesis. Blood 62: 1-13.
Mosmann T. (1983). Rapid colorimetric assay for cellular
growth and survival: application to proliferation and cyto-
toxicity assays. J. Immunol. Meth. 65: 55-63.
Parnes J.R., Velan B., Felsenfeld A., Ramanathan L., Ferrini
U., Appella E., and Seidman J.G. (1981). Mouse//2-microglo-
bulin cDNA clones: A screening procedure for cDNA
clones corresponding.to rare mRNAs. Proc. Natl. Acad. Sci.
USA 78: 2253-2257.
Ralph S.J., Thomas M.L., Morton C.C., and Trowbridge I.S.
(1987). Structural variants of human T200 glycoprotein
(leukocyte common antigen). EMBO J. 6:1251-1257.
Raschke W.G., Baird S., Ralph P., and Nakoinz I. (1978). Func-
tional macrophage cell lines transformed by Abelson leuke-
mia virus. Cell 15: 261-267.
Rave N., Ckvenjakou R., and Blodtker H. (1979). Identifi-
cation of procollagen mRNAs transferred to DBM paper
from formaldehyde agarose gels. Nucl. Acids Res. 6:
3559-3567.
Rigby P.W., Dieckmann M., Rhodes C., and Berg P. (1979).
Labeling deoxyribonucleic acid to high specific activity in
vitro by nick translation with DNA polymerase I. J. Mol.
Biol. 113: 237-251.
Rogers J., Early P., Carter C., Calame K., Bond M., Hood L.,
and Wall R. (1980). Two mRNAs with different 3’ ends
encode membrane-bound and secreted forms of immunog-
lobulin/a chain. Cell 20: 303-312.
Saga Y., Tung J.S., Shen F.W., and Boyse E.A. (1987). Alterna-
tive use of 5’ exons in the specification of Ly-5 isoforms dis-
tinguishing hematopoietic cell lineages. Proc. Natl. Acad.
Sci. USA 84: 5364-5368.
Schwartz R.C., Sonenshein G.E., Bothwell A., and Gefter M.L.
(1981). Multiple expression of Ig -chain encoding RNAANTIGEN PRESENTATION AFTER LINEAGE SWITCH 261
species in murine plasmacytoma cells. J. Immunol. 126:
2104-2108.
Schwartz R.C., Stanton L.W., Marcu K.B., and Witts O.N.
(1986a). An in vitro model for tumor progresesion in murine
lymphoid cells. Curr. Top. Microbiol. Immunol. 132: 75-80.
Schwartz R.C Stanton L.W., Riley S.C., Marcu K.B and
Witte O.N. (’986b). Synergism of v-myc and v-Ha-ras’ithe
in vitro neoplastic progression of murine lymphoid cells.
Mol. Cell. Biol. 6: 3221-3231.
Seidman J.G., and Leder P. (1978). The arrangement and
rearrangement of antibody genes. Nature 276: 790-795.
Sheng-Ong G.L.C., Holmes K.L., and Morse H.C. (1987).
Phorbol ester-induced growth arrest of murine myelomon-
ocytic leukemic cells with virus disrupted myb locus is not
accompanied by decreased myc and myb expression. Proc.
Natl. Acad. Sci. USA 84: 199-203.
Silver J., and Kozak C. (1986). Common proviral integration
region on mouse chromosome 7 in lymphomas and myelog-
enous leukemias induced by Friend murine leukemia virus.
J. Virol. 57: 526-533.
Southern E.M. (1975). Detection of specific sequences among
DNA fragments separated by gel electrophoresis. J. Mol.
Biol. 98: 502-517.
Springer T., Galfre G., Secher D.S., and Milstein C. (1979).
Mac-l: A macrophage differentiation antigen identified by
a monoclonal antibody. Eur. J. Immunol. 9: 301-306.
Stanton L.W., Fahrlander P.D., Tesser P.M., and Marcu K.B.
(1984). Nucleotide sequence comparison of normal and
translocated murine c-myc genes. Nature 310: 423-425.
Streuli M., Hall L.R., Saga Y., Schlossman S.F., and Saito H.
(1987). Differential usage of three exons generates at least
five different mRNAs encoding human leukocyte common
antigens. J. Exp. Med. 166: 1548-1566.
Thomas M.L., Reynolds P.J., Chain A., Ben-Neriah Y., and
Trowbridge I.S. (1987). B-cell variant of mouse T200 (Ly-5):
Evidence for alternative mRNA splicing. Proc. Natl. Acad.
Sci. USA 84: 5360-5363.
Thomas P. (1980). Hybridization of denatured RNA and small
DNA fragments transferred to nitrocellulose. Proc. Natl.
Acad. Sci. USA 77: 5201-5205.
Walker E., Warner N.L., Chesnut R., Kappler J., and Marrack
P. (1982). Antigen-specific, region-restricted interactions
in vitro between tumor cell lines and T cell hybridomas. J.
Immunol. 128: 2164-2169.
White J., Haskins K.M., Marrack P., and Kappler J. (1983). Use
of region-restricted, antigen-specific T cell hybridomas to
produce idiotypically specific anti-receptor antibodies. J.
Immunol. 130:1033-1037.
Whitlock C.A., Ziegler S.F., Treiman L.J., Stafford J.I., and
Witte O.N. (1983). Differentiation of cloned populations of
immature B cells after transformation with Abelson murine
leukemia virus. Cell 32:903-911.
Yam L.T., Li C.Y., and Crosby W.H. (1971). Cytochemical
identification of monocytes and granulocytes. Am. J. Clin.
Path. 55: 283-290.